Rain Therapeutics Stock (NASDAQ: RAIN)
|Day Range- - -||52 Wk Range2.15 - 14.03||Open / Close- / -||Float / Outstanding6.5M / 26.6M|
|Vol / Avg.- / 75.4K||Mkt Cap104.7M||P/E-||50d Avg. Price6.34|
|Div / Yield-||Payout Ratio-||Total Float6.5M||EPS-0.66|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Rain Therapeutics (NASDAQ: RAIN) through any online brokerage.
The latest price target for Rain Therapeutics (NASDAQ: RAIN) was reported by HC Wainwright & Co. on Monday, September 12, 2022. The analyst firm set a price target for 10.00 expecting RAIN to rise to within 12 months (a possible 153.81% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Rain Therapeutics (NASDAQ: RAIN) is $3.94 last updated October 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Rain Therapeutics.
Rain Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Rain Therapeutics.
Rain Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.